Reuters – The U.S. Food and Drug Administration (FDA) has warned more than a dozen companies against selling unapproved products which claim to treat Alzheimer’s disease and other serious ailments, the agency said on Monday. Many of these drugs, marketed as dietary supplements and sold online, have not been reviewed by the FDA and their safety and efficacy remain unproven, the agency said in a statement.